Drugs Made In America Acquisition (DMIIR) Current Assets (2024 - 2025)
Drugs Made In America Acquisition's (DMIIR) quarterly Current Assets came in at $26037.0 in Q4 2025, down 56.32% year-on-year from $59615.0 in Q4 2024, and down 97.1% on a QoQ basis from $896356.0 in Q3 2025.
Drugs Made In America Acquisition (DMIIR) Current Assets (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMIIR) has 2 years of Current Assets data on file, last reported at $26037.0 in Q4 2025.
- On a quarterly basis, Current Assets fell 56.32% year-over-year to $26037.0 in Q4 2025; TTM through Dec 2025 was $26037.0, a 56.32% decrease from a year earlier, with the FY2025 full-year figure at $26037.0, down 56.32% from the prior year.
- Current Assets for Q4 2025 stood at $26037.0, down from $896356.0 in the prior quarter.
- Over the last five years, Current Assets for DMIIR reached as high as $896356.0 in Q3 2025 and fell as low as $26037.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 480.75 Mn | 480.75 Mn | - | 1.58 Mn |
| 2 | Agriculture & Natural Solutions Acquisition | 393.29 Mn | 393.29 Mn | - | 214,543.00 |
| 3 | Berto Acquisition | 314.56 Mn | 314.35 Mn | - | 405,162.00 |
| 4 | GP-Act III Acquisition | 313.66 Mn | 313.66 Mn | - | 188,111.00 |
| 5 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 54,530.00 |
| 6 | Republic Digital Acquisition | 310.50 Mn | 309.63 Mn | - | 1.01 Mn |
| 7 | Siddhi Acquisition Corp (Cayman Islands) | 288.97 Mn | 288.97 Mn | - | 595,733.00 |
| 8 | K&F Growth Acquisition | 283.42 Mn | 283.42 Mn | - | 727,191.00 |
| 9 | Bold Eagle Acquisition | 275.29 Mn | 275.29 Mn | - | 665,298.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | 26,037.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,037.00 |
| Sep 30, 2025 | 896,356.00 |
| Dec 31, 2024 | 59,615.00 |